You have read all your free articles, to continue reading subscribe to read the rest of this content.
Most listed Swedish biotech companies have cash and financing that is sufficient to last until 2023 or longer. The few who do not have this should probably hurry while there is time. During 2023-2025, many companies will return for new funds and competition will be fierce. In addition, there are…
Medivir has announced that its Board of Directors has appointed Yilmaz Mahshid as the new CEO of the company. Yilmaz Mahshid has long and broad experience from qualified roles in the life science sector, the company states. He succeeds Uli Hacksell, who has been CEO since October 2018. Mahshid wiAlready…
Asarina Pharma, a drug development company focused on the development of a novel therapy for severe premenstrual symptoms, has completed a financing round raising EURO 7 million from new and existing investors for the continued clinical development of Sepranolone. Around 5% of women in fertile agAlready a subscriber Login You…
Orion is planning to change and refocus the strategy of its R&D function and in the future focus would be on cancer and pain. Orion will initiate negotiations concerning in total 430 salaried employees and senior salaried employees in Finland in Espoo, Turku and Kuopio in the research areas iAlready…
